Navigation Links
CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
Date:2/24/2009

LAS VEGAS, Feb. 24 /PRNewswire-FirstCall/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) announced today that two additional hospitals in the United States opened for patient enrollment for its ACORD Phase II clinical trial for the treatment of severe coronary heart disease. The sites are Florida Hospital/Cardiovascular Institute - Orlando Florida and Chandler Regional Medical Center and Mercy Gilbert Medical Center - Phoenix Arizona metropolitan area.

Mercy Hospital Fairfield (Ohio) and The Christ Hospital in Cincinnati, Ohio were first to open for enrollment in early September, and are working in collaboration to screen and treat patients in the trial. They treated their first patient in support of the trial in mid November 2008.

CVBT now has seven sites that are open for enrollment and intends to announce additional sites as they open for screening patents.

About CardioVascular BioTherapeutics

CVBT (OTCBB: CVBT) is a biopharmaceutical company developing human FGF-1 for cardiovascular diseases characterized by inadequate blood flow to a tissue or organ. In addition to the Phase II trial it is conducting in patients with severe coronary heart disease, the company has two FDA-authorized clinical trials in the areas of impaired wound healing seen in diabetics and in patients suffering from peripheral artery disease of the legs. An additional study is being conducted in patients with chronic back pain who may have perfusion defects to their spine. For more information about CardioVascular BioTherapeutics, Inc. please visit www.cvbt.com.

    Media Contact:
    Allison Caplan,
    CardioVascular BioTherapeutics, Inc.
    (702) 839-7200, acaplan@cvbt.com

    Investor Contact:
    Yvonne Johnson
    CardioVascular BioTherapeutics, Inc.
    (702) 839-7220
'/>"/>
SOURCE  CardioVascular BioTherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 

Related medicine technology :

1. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
2. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
3. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
4. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
5. Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
8. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
9. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
10. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...wswire-FirstCall/ -- The U.S. Food and Drug Admi...nzapine) in tablet form as an option for the treat...associated with bipolar I disorder in adolescents ...abel states that clinicians should take into consi...nd hyperlipidemia in adolescents compared to adult...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc...st an investor teleconference and webcast. Princi...ons surrounding carfilzomib in relapsed and/or ref...American Society of Hematology (ASH) Annual Meetin.... CT/10:00 a.m. ET on Monday, December 7, 2009. T...
(Date:12/4/2009)...4 Chemistry World rec... Pharmaceutical Research and Manufacturers of Amer...ccines in development for HIV/AIDS and related con...roducts in development include 23 vaccines and 54 ...al trials or awaiting approval by the U.S. Food an...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 1Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 3Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 1Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 1The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 3
(Date:12/4/2009)... are recruited annually to participate in clinical...ch Protection (AHRP), and most will be compensated...tions view payments to volunteers as compensation ...ential risks related to participating in the exper...e a very different view of clinical trial compensa...
(Date:12/4/2009)...it consumption leads to success, study finds , ...reased exercise, reduced soda consumption and self...rol strategies for adolescents, a new study shows....heir weight-control strategies and lifestyle habit... had not. The responses were grouped into four cat...
(Date:12/4/2009)...r at-risk patient groups , , FRIDAY, Dec...rticularly Ewing sarcomas and central nervous syst... researchers have found. , The study authors an... most common pediatric cancers who were enrolled i...searchers found that the overall cancer recurrence...
(Date:12/4/2009)...y hesitate to take breast cancer drug, study finds...Worries about side effects are a major reason why ...breast cancer are willing to take the drug tamoxif... In an effort to inform women about the risks and ...ty of Michigan Comprehensive Cancer Center created...
(Date:12/4/2009)...la., Dec. 4 Today, seven of Florid...in improving the health of Florida,s uninsured and...Florida,s 2009 Sapphire Award ceremony. ,, The ...hat recognizes and promotes organizations that hav...parities within their communities. ,, Honorees ...
Breaking Medicine News(10 mins):Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
...tional AIDS Vaccine Initiative (IAVI) together wit...have announced a public-private partnership to dev...uman primate adenovirus vector technology was deri...GSK. According to the agreement, IAVI and GS...
...vening the U.S. Food and Drug Administration order...beling as several cases have been reported to caus...ed that all consumers should stop taking impotency...s. This move was followed by an announcemen...
... provide quick relief from post pregnancy depressi...women who may be more vulnerable to this type of d...he condition. However a recent study by the resear... depression but the treatment meted out to the pre...
...h teams working independently have identified how ...lls to cause infections. Hendra virus belongs...wn to cause an outbreak of respiratory and neurolo...s, mostly in men. Researchers have found that...
...hod to reduce the risk of deaths from advanced pro... method of screening. A recent study suggests that...aths. Prostate cancer is the most frequently ...ady spread to other organs. PSA blood test is a si...
... of two human clinical trials support the enhance...ges using its novel technology which will interest... its bioavailability, or the body's absorption of ...e emulsifiers and solvents to trap water droplets ...
Other Medicine News:Health News:Developing a new vaccine using a new technology 2Health News:Screening For Prostate Cancer May Reduce Mortality Rate 2
HCS INTERACTANT Application Financial System Solutions
Infinity Amylase CNPG3 (Liquid)
Infinity Uric Acid (Powder)
...owder reagent once reconstituted offers the labora...y to help maximize laboratory productivity, minimi...und time. The proprietary technology of the Infini...elf life and stability once reconstituted that wil...
Medicine Products: